Local ablative treatment for synchronous single organ oligometastatic lung cancer-A propensity score analysis of 180 patients

LAT was the strongest predictor for PFS and OS in OMD with ≤4 metastases. Survival in the control group identifies OMD as a subset of lung cancer with a generally more favorable prognosis.